Nomogram to predict overall survival in patients with primary bladder neuroendocrine carcinoma: a population-based study
Future Oncology · 01.12.2022 · 18 (38) · 4171-4181
DOI: 10.2217/fon-2022-0843 ↗Kurz gefasst
Fachartikel in der Zeitschrift Future Oncology, online erschienen am 18.01.2023. Verfasst von Sheng Li und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Nanchang, China. Hauptthemen laut MEDLINE: Carcinoma, Neuroendocrine, Urinary Bladder Neoplasms. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Jiangxi Provincial "Double Thousand Plan" Fund Project, Jiangxi Provincial “Double Thousand Plan” Fund Project.
Abstract (Originalsprache)
Aim
To develop a prognostic model to predict the overall survival of primary bladder neuroendocrine carcinoma (BNEC) patients.
Methods
Using univariate and multivariate Cox regression analyses, a nomogram was constructed. Calibration curves, receiver operating characteristic curves and C-index were utilized to evaluate the performance.
Results
The study enrolled 906 BNEC patients. The following variables were incorporated in the nomogram: age, marital status, Tumor node metastasis (TNM) stage, chemotherapy and surgery. The nomogram had a C-index of 0.702 in the training cohort and 0.724 in the validation cohort.
Conclusion
Compared with the TNM staging system, the proposed nomogram exhibits superior prognostic discrimination and survival prediction. Neuroendocrine bladder cancer accounts for
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Urology, Nanchang, China.
- The First Affiliated Hospital of Nanchang University, No.17, Yongwai Zhengjie, Donghu District, Nanchang City, Jiangxi Province, 330000, China.
Förderung
- Jiangxi Provincial "Double Thousand Plan" Fund Project
- Jiangxi Provincial “Double Thousand Plan” Fund Project
Zitieren
APA
Li, S., Liu, X., Weipeng, L., & Fu, B. (2022). Nomogram to predict overall survival in patients with primary bladder neuroendocrine carcinoma: a population-based study. Future Oncology, 18(38), 4171-4181. https://doi.org/10.2217/fon-2022-0843
Vancouver
Li S, Liu X, Weipeng L, Fu B. Nomogram to predict overall survival in patients with primary bladder neuroendocrine carcinoma: a population-based study. Future Oncology. 2022;18(38):4171-4181. doi:10.2217/fon-2022-0843
BibTeX
@article{Li2022,
author = {Li, Sheng and Liu, Xiaoqiang and Weipeng, Liu and Fu, Bin},
title = {Nomogram to predict overall survival in patients with primary bladder neuroendocrine carcinoma: a population-based study},
journal = {Future Oncology},
year = {2022},
volume = {18},
number = {38},
pages = {4171--4181},
doi = {10.2217/fon-2022-0843}
}
EUVIMED